ArticleBMC cancer2016

Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement.

Jieyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.